Literature DB >> 11014954

Pure versus complicated vulvar vestibulitis: a randomized trial of fluconazole treatment.

J Bornstein1, G Livnat, Z Stolar, H Abramovici.   

Abstract

OBJECTIVE: To examine the effectiveness of a 6-month treatment consisting of a weekly oral dose of 150 mg fluconazole for women with vestibulitis, and to explore the causes of treatment failure.
METHODS: Forty women with vestibulitis were randomized to either of two treatment groups. One group received a 6-month low oxalate diet with calcium citrate complement, as a placebo, and the second group the same diet and calcium citrate with the addition of a weekly oral tablet of 150 mg fluconazole. The women were examined 3 months after completing treatment, for response to therapy.
RESULTS: The addition of intensive 6-month fluconazole treatment did not lead to an outcome better than that attained by maintaining a low oxalate diet with calcium citrate supplementation. The satisfactory response rate was 15 and 30%, respectively. The presence of 'complicated vestibulitis', candidiasis concomitant with vestibulitis, decreases the satisfactory response rate regardless of the type of treatment administered (odds ratio 19.9, 95% CI 1.6, 250).
CONCLUSION: Prolonged oral fluconazole is an ineffective treatment of vestibulitis, whether pure or complicated by concomitant vulvovaginal candidiasis. The coexistence of candidiasis and vestibulitis - complicated vestibulitis - might represent a subset of vestibulitis that is resistant to the currently available medical therapy. Copyright 2000 S. Karger AG, Basel

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11014954     DOI: 10.1159/000010309

Source DB:  PubMed          Journal:  Gynecol Obstet Invest        ISSN: 0378-7346            Impact factor:   2.031


  5 in total

1.  Recruitment methods in a clinical trial of provoked vulvodynia: Predictors of enrollment.

Authors:  Candi C Bachour; Gloria A Bachmann; David C Foster; Jim Y Wan; Leslie A Rawlinson; Candace S Brown
Journal:  Clin Trials       Date:  2016-08-11       Impact factor: 2.486

Review 2.  A review of the available clinical therapies for vulvodynia management and new data implicating proinflammatory mediators in pain elicitation.

Authors:  M L Falsetta; D C Foster; A D Bonham; R P Phipps
Journal:  BJOG       Date:  2016-06-17       Impact factor: 6.531

3.  The tampon test for vulvodynia treatment outcomes research: reliability, construct validity, and responsiveness.

Authors:  David C Foster; Merrill Beth Kotok; Li-Shan Huang; Arthur Watts; David Oakes; Fred M Howard; Chris J Stodgell; Robert H Dworkin
Journal:  Obstet Gynecol       Date:  2009-04       Impact factor: 7.661

4.  Vulvar vestibulitis syndrome.

Authors:  Carolyn Gardella
Journal:  Curr Infect Dis Rep       Date:  2006-11       Impact factor: 3.663

Review 5.  Etiology, diagnosis, and clinical management of vulvodynia.

Authors:  Leslie A Sadownik
Journal:  Int J Womens Health       Date:  2014-05-02
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.